These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 21370270)

  • 1. Illusory misidentifications and cortical hypometabolism in Parkinson's disease.
    Ishioka T; Hirayama K; Hosokai Y; Takeda A; Suzuki K; Nishio Y; Sawada Y; Takahashi S; Fukuda H; Itoyama Y; Mori E
    Mov Disord; 2011 Apr; 26(5):837-43. PubMed ID: 21370270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cerebral glucose metabolism of Parkinson's disease patients with mild cognitive impairment.
    Lyoo CH; Jeong Y; Ryu YH; Rinne JO; Lee MS
    Eur Neurol; 2010; 64(2):65-73. PubMed ID: 20606450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining visual illusions in Parkinson's disease: Kinetopsia and object misidentification illusions.
    Nishio Y; Yokoi K; Hirayama K; Ishioka T; Hosokai Y; Gang M; Uchiyama M; Baba T; Suzuki K; Takeda A; Mori E
    Parkinsonism Relat Disord; 2018 Oct; 55():111-116. PubMed ID: 29891431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pareidolia in Parkinson's disease without dementia: A positron emission tomography study.
    Uchiyama M; Nishio Y; Yokoi K; Hosokai Y; Takeda A; Mori E
    Parkinsonism Relat Disord; 2015 Jun; 21(6):603-9. PubMed ID: 25864093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired perception of illusory contours and cortical hypometabolism in patients with Parkinson's disease.
    Ishioka T; Hirayama K; Hosokai Y; Takeda A; Suzuki K; Nishio Y; Sawada Y; Abe N; Mori E
    Neuroimage Clin; 2021; 32():102779. PubMed ID: 34418792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cerebral glucose metabolism between multiple system atrophy Parkinsonian type and Parkinson's disease.
    Feng T; Wang Y; Ouyang Q; Duan Z; Li W; Lu L; Xiang W
    Neurol Res; 2008 May; 30(4):377-82. PubMed ID: 18544255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Grey matter hypometabolism and atrophy in Parkinson's disease with cognitive impairment: a two-step process.
    González-Redondo R; García-García D; Clavero P; Gasca-Salas C; García-Eulate R; Zubieta JL; Arbizu J; Obeso JA; Rodríguez-Oroz MC
    Brain; 2014 Aug; 137(Pt 8):2356-67. PubMed ID: 24951642
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal study of cognitive and cerebral metabolic changes in Parkinson's disease.
    Baba T; Hosokai Y; Nishio Y; Kikuchi A; Hirayama K; Suzuki K; Hasegawa T; Aoki M; Takeda A; Mori E
    J Neurol Sci; 2017 Jan; 372():288-293. PubMed ID: 28017230
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Characteristics of cerebral glucose metabolism in patients with cognitive impairment in Parkinson's disease].
    Homenko JG; Susin DS; Kataeva GV; Irishina JA; Zavolokov IG
    Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(5):46-51. PubMed ID: 28638030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative normalization methods demonstrate widespread cortical hypometabolism in untreated de novo Parkinson's disease.
    Berti V; Polito C; Borghammer P; Ramat S; Mosconi L; Vanzi E; De Cristofaro MT; De Leon M; Sorbi S; Pupi A
    Q J Nucl Med Mol Imaging; 2012 Jun; 56(3):299-308. PubMed ID: 22695340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct comparison between regional cerebral metabolism in progressive supranuclear palsy and Parkinson's disease.
    Klein RC; de Jong BM; de Vries JJ; Leenders KL
    Mov Disord; 2005 Aug; 20(8):1021-30. PubMed ID: 15858809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resting regional cerebral glucose metabolism in advanced Parkinson's disease studied in the off and on conditions with [(18)F]FDG-PET.
    Berding G; Odin P; Brooks DJ; Nikkhah G; Matthies C; Peschel T; Shing M; Kolbe H; van Den Hoff J; Fricke H; Dengler R; Samii M; Knapp WH
    Mov Disord; 2001 Nov; 16(6):1014-22. PubMed ID: 11748732
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment in drug-naive patients with PD is associated with cerebral hypometabolism.
    Pappatà S; Santangelo G; Aarsland D; Vicidomini C; Longo K; Bronnick K; Amboni M; Erro R; Vitale C; Caprio MG; Pellecchia MT; Brunetti A; De Michele G; Salvatore M; Barone P
    Neurology; 2011 Oct; 77(14):1357-62. PubMed ID: 21940621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypermetabolism in the cerebellum and brainstem and cortical hypometabolism are independently associated with cognitive impairment in Parkinson's disease.
    Blum D; la Fougère C; Pilotto A; Maetzler W; Berg D; Reimold M; Liepelt-Scarfone I
    Eur J Nucl Med Mol Imaging; 2018 Dec; 45(13):2387-2395. PubMed ID: 30008111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional cortical grey matter loss in Parkinson's disease without dementia is independent from visual hallucinations.
    Meppelink AM; de Jong BM; Teune LK; van Laar T
    Mov Disord; 2011 Jan; 26(1):142-7. PubMed ID: 20922809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metabolic alterations in patients with Parkinson disease and visual hallucinations.
    Boecker H; Ceballos-Baumann AO; Volk D; Conrad B; Forstl H; Haussermann P
    Arch Neurol; 2007 Jul; 64(7):984-8. PubMed ID: 17620488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Brain metabolic correlates of fatigue in Parkinson's disease: a PET study.
    Zhang L; Li T; Yuan Y; Tong Q; Jiang S; Wang M; Wang J; Ding J; Xu Q; Zhang K
    Int J Neurosci; 2018 Apr; 128(4):330-336. PubMed ID: 28918694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemispheric specialization of the basal ganglia during vocal emotion decoding: Evidence from asymmetric Parkinson's disease and
    Stirnimann N; N'Diaye K; Jeune FL; Houvenaghel JF; Robert G; Drapier S; Drapier D; Grandjean D; Vérin M; Péron J
    Neuropsychologia; 2018 Oct; 119():1-11. PubMed ID: 30040955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease.
    Baba T; Takeda A; Kikuchi A; Nishio Y; Hosokai Y; Hirayama K; Hasegawa T; Sugeno N; Suzuki K; Mori E; Takahashi S; Fukuda H; Itoyama Y
    Mov Disord; 2011 Mar; 26(4):621-8. PubMed ID: 21284041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cortical hypometabolism assessed by a metabolic ratio in Parkinson's disease primarily reflects cognitive deterioration-[18F]FDG-PET.
    Liepelt I; Reimold M; Maetzler W; Godau J; Reischl G; Gaenslen A; Herbst H; Berg D
    Mov Disord; 2009 Jul; 24(10):1504-11. PubMed ID: 19489069
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.